Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Neoplasms 93Breast Neoplasms 79Lung Neoplasms 50Prostatic Neoplasms 45Colorectal Neoplasms 33Carcinoma, Non-Small-Cell Lung 31Pancreatic Neoplasms 29Hematologic Neoplasms 22Lymphoma 19Brain Neoplasms 19Stomach Neoplasms 17Ovarian Neoplasms 17Urinary Bladder Neoplasms 15Multiple Myeloma 14Melanoma 14Liver Neoplasms 14Leukemia, Myeloid, Acute 14Head and Neck Neoplasms 13Esophageal Neoplasms 13Carcinoma, Hepatocellular 13Uterine Cervical Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Non-Hodgkin 12Leukemia 12Disease 12Carcinoma, Renal Cell 12Leukemia, Lymphocytic, Chronic, B-Cell 11Kidney Neoplasms 11Colonic Neoplasms 11Glioma 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Macrophage Activation Syndrome × 30 days × Clear all
NCT03827343 2026-06-05

Retrospective Study of Immunotherapy Related Toxicities and Factors Impacting Outcomes in Children and Adults With Cancer

National Institutes of Health Clinical Center (CC)

Active not recruiting
500 enrolled
Myeloid

Lymphohistiocytosis, Hemophagocytic, Macrophage Activation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡